Kartal Ayşenur Sinem, Kartal Mehmet Oğuz, Gülleroğlu Nadide Başak, Sarı Neriman, İlhan İnci Ergürhan, Gülaldı Nedim C M
University of Health Sciences, Department of Nuclear Medicine, Ankara Bilkent City Hospital, Ankara, Türkiye.
University of Health Sciences, Department of Pediatric Radiology, Ankara Bilkent City Hospital, Ankara, Türkiye.
Eur J Nucl Med Mol Imaging. 2025 May 26. doi: 10.1007/s00259-025-07359-z.
We aimed to investigate the value of primary tumour F-18 fluorodeoxyglucose (F-FDG) parameters and textural features in predicting tumour response to neoadjuvant chemoradiotherapy (neo-CRT) and prognosis in paediatric patients with soft tissue sarcoma (STS).
Twenty-eight paediatric patients with STS who underwent F-FDG PET/CT studies before neo-CRT were included in this retrospective and single-center study. SUVmax, SUVpeak, SUVmean, metabolic tumour volume (MTV, 40% SUVmax), total lesion glycolysis (TLG), and textural features were extracted from the primary tumour volumes delineated semiautomatically on the baseline PET images. Patients were classified as responders or non-responders according to Response Evaluation Criteria in Solid Tumors 1.1. A receiver operating characteristic (ROC) analysis was performed. The highest AUC values within their respective quantitative groups were selected for further analysis, including logistic regression analysis for response prediction and Cox regression analysis for survival prediction.
In univariate analysis SUVmax > 13.0 (p = 0.009), SUVpeak > 12.7 (p = 0.017), Histogram Entropy > 0.97 (p = 0.036), and NGTDM Busyness < 0.37 (p = 0.005) were associated with tumour response for the median follow-up of 25 months. NGTDM Busyness was an independent predictor for the treatment response (OR: 30.5; 95% CI: 1.50-618.5; p = 0.026). Age was associated with progression (Cut-off: 11 years, [AUC:0.73 (95% CI: 0,53 - 0,93)] 𝑝=0.022). Progression-free survival outcomes were assessed in aged > 11 years subpopulation. PFS was significantly shorter in patients with high GLSZM_GLNU (p = 0,024), GLSZM_ZSNU (p = 0,003), and TLG (p = 0,016). In multivariate analysis GLSZM_ZSNU > 13,04 (HR: 11.61; 95% CI: 1.35-54.02; p = 0.026) was an independent predictor of PFS in subpopulation aged > 11 years.
Heterogeneity texture features Histogram Entropy and NGTDM Busyness and metabolic PET parameters (SUV max and SUVpeak) can predict tumour response. In aged > 11 years patients subgroup analyses, GLSZM ZSNU was an independent factor for PFS.
我们旨在研究原发性肿瘤F-18氟脱氧葡萄糖(F-FDG)参数和纹理特征在预测小儿软组织肉瘤(STS)患者对新辅助放化疗(neo-CRT)的反应及预后中的价值。
本回顾性单中心研究纳入了28例在neo-CRT前接受F-FDG PET/CT检查的小儿STS患者。从基线PET图像上半自动勾勒出的原发性肿瘤体积中提取SUVmax、SUVpeak、SUVmean、代谢肿瘤体积(MTV,40% SUVmax)、总病变糖酵解(TLG)和纹理特征。根据实体瘤疗效评价标准1.1将患者分为反应者或无反应者。进行了受试者工作特征(ROC)分析。在各自的定量组中选择最高的AUC值进行进一步分析,包括用于反应预测的逻辑回归分析和用于生存预测的Cox回归分析。
在单因素分析中,中位随访25个月时,SUVmax>13.0(p = 0.009)、SUVpeak>12.7(p = 0.017)、直方图熵>0.97(p = 0.036)和邻域灰度差矩阵繁忙度<0.37(p = 0.005)与肿瘤反应相关。邻域灰度差矩阵繁忙度是治疗反应的独立预测因子(OR:30.5;95% CI:1.50 - 618.5;p = 0.026)。年龄与进展相关(临界值:11岁,[AUC:0.73(95% CI:0.53 - 0.93)] p = 0.022)。在年龄>11岁的亚组中评估无进展生存结果。高GLSZM_GLNU(p = 0.024)、GLSZM_ZSNU(p = 0.003)和TLG(p = 0.016)的患者无进展生存期明显较短。在多因素分析中,GLSZM_ZSNU>13.04(HR:11.61;95% CI:1.35 - 54.02;p = 0.026)是年龄>11岁亚组中无进展生存期的独立预测因子。
异质性纹理特征直方图熵和邻域灰度差矩阵繁忙度以及代谢PET参数(SUV max和SUVpeak)可预测肿瘤反应。在年龄>11岁患者的亚组分析中,GLSZM ZSNU是无进展生存期的独立因素。